A U.S. House subcommittee will hear testimony next week on how “reining in” pharmacy benefit managers (PBMs) could improve drug [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
340B contract pharmacy access bills could cost states millions and employer health plans more, according to a new study funded [...] …
A Republican congressman praised NYU Langone Health’s “prudent financial management” Wednesday—just days after publicly pressing the New York City health [...] …
The U.S. Senate voted largely along party lines Thursday to confirm Robert F. Kennedy Jr. as President Donald Trump’s pick [...] …
Congressional Republicans this week unveiled and began marking up budget plans that call for major cuts to federal healthcare spending—which [...] …
Tom Engels, who served as Health Resources and Services Administration (HRSA) administrator during the last two years of President Donald [...] …
A national group representing 1,500-plus 340B hospitals and two of its members have filed to intervene in federal court cases [...] …
A Boston-based drugmaker recently added a newly approved non-opiate pain treatment to the list of drugs subject to its 340B [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Building America’s Future (BAF), a powerful conservative dark money group with ties to the Trump administration, contributed almost $5 million [...] …